LianBio ADR Probability of Future Stock Price Finishing Over 2.18
| LIANDelisted Stock | USD 2.18 0.05 2.24% |
LianBio |
LianBio ADR Target Price Odds to finish over 2.18
The tendency of LianBio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.18 | 90 days | 2.18 | about 81.45 |
Based on a normal probability distribution, the odds of LianBio ADR to move above the current price in 90 days from now is about 81.45 (This LianBio ADR probability density function shows the probability of LianBio Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days LianBio ADR has a beta of 0.58. This indicates as returns on the market go up, LianBio ADR average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding LianBio ADR will be expected to be much smaller as well. Additionally LianBio ADR has an alpha of 0.0907, implying that it can generate a 0.0907 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). LianBio ADR Price Density |
| Price |
Predictive Modules for LianBio ADR
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as LianBio ADR. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.LianBio ADR Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. LianBio ADR is not an exception. The market had few large corrections towards the LianBio ADR's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold LianBio ADR, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of LianBio ADR within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.09 | |
β | Beta against Dow Jones | 0.58 | |
σ | Overall volatility | 0.19 | |
Ir | Information ratio | 0.01 |
LianBio ADR Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of LianBio ADR for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for LianBio ADR can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| LianBio ADR is not yet fully synchronised with the market data | |
| LianBio ADR has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (87.98 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| LianBio ADR currently holds about 329.3 M in cash with (83.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 79.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Hookipa Pharma price target lowered to 7 from 24 at JMP Securities - TipRanks |
LianBio ADR Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of LianBio Stock often depends not only on the future outlook of the current and potential LianBio ADR's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. LianBio ADR's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 107.9 M | |
| Cash And Short Term Investments | 302.4 M |
LianBio ADR Technical Analysis
LianBio ADR's future price can be derived by breaking down and analyzing its technical indicators over time. LianBio Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of LianBio ADR. In general, you should focus on analyzing LianBio Stock price patterns and their correlations with different microeconomic environments and drivers.
LianBio ADR Predictive Forecast Models
LianBio ADR's time-series forecasting models is one of many LianBio ADR's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary LianBio ADR's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about LianBio ADR
Checking the ongoing alerts about LianBio ADR for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for LianBio ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| LianBio ADR is not yet fully synchronised with the market data | |
| LianBio ADR has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (87.98 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| LianBio ADR currently holds about 329.3 M in cash with (83.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 79.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Hookipa Pharma price target lowered to 7 from 24 at JMP Securities - TipRanks |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in LianBio Stock
If you are still planning to invest in LianBio ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LianBio ADR's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |